<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">        <PMID Version="1">30275856</PMID>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>04</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Print">1738-6756</ISSN>                <JournalIssue CitedMedium="Print">                    <Volume>21</Volume>                    <Issue>3</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                    </PubDate>                </JournalIssue>                <Title>Journal of breast cancer</Title>                <ISOAbbreviation>J Breast Cancer</ISOAbbreviation>            </Journal>            <ArticleTitle>Long Noncoding RNA Signature and Disease Outcome in Estrogen Receptor-Positive Breast Cancer Patients Treated with Tamoxifen.</ArticleTitle>            <Pagination>                <MedlinePgn>277-287</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.4048/jbc.2018.21.e39</ELocationID>            <Abstract>                <AbstractText Label="Purpose" NlmCategory="UNASSIGNED">Recent data have shown that the expression levels of long noncoding RNAs (lncRNAs) are associated with tamoxifen sensitivity in estrogen receptor (ER)-positive breast cancer. Herein, we constructed an lncRNA-based model to predict disease outcomes of ER-positive breast cancer patients treated with tamoxifen.</AbstractText>                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">LncRNA expression information was acquired from Gene Expression Omnibus by re-mapping pre-existing microarrays of patients with ER-positive breast cancer treated with tamoxifen. The distant metastasis-free survival (DMFS) predictive signature was subsequently built based on a Cox proportional hazard regression model in discover cohort patients, which was further evaluated in another independent validation dataset.</AbstractText>                <AbstractText Label="Results" NlmCategory="UNASSIGNED">Six lncRNAs were found to be associated with DMFS in the discover cohort, which were used to construct a tamoxifen efficacy-related lncRNA signature (TLS). There were 133 and 362 patients with TLS high- and low-risk signatures in the discover cohort. Both univariate and multivariate analysis demonstrated that TLS was associated with DMFS. TLS high-risk patients had worse outcomes than low-risk patients, with a hazard ratio of 4.04 (95% confidence interval, 2.83-5.77; <i>p</i>&lt;0.001). Both subgroup analysis and receiver operating characteristic analysis indicated that TLS performed better in lymph node-negative, luminal B, 21-gene recurrence score high-risk, and 70-gene prognosis signature high-risk patients. Moreover, in a comparison of the 21-gene recurrence score and 70-gene prognosis signature, TLS showed a similar area under receiver operating characteristic curve in all patients. Gene Set Enrichment Analysis indicated that TLS high-risk patients showed different gene expression patterns related to the cell cycle and nucleotide metabolism from those of low-risk patients.</AbstractText>                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">This six-lncRNA signature was associated with disease outcome in ER-positive breast cancer patients treated with tamoxifen, which is comparable to previous messenger RNA signatures and requires further clinical evaluation.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Wang</LastName>                    <ForeName>Gen</ForeName>                    <Initials>G</Initials>                    <AffiliationInfo>                        <Affiliation>Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Chen</LastName>                    <ForeName>Xiaosong</ForeName>                    <Initials>X</Initials>                    <AffiliationInfo>                        <Affiliation>Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Liang</LastName>                    <ForeName>Yue</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wang</LastName>                    <ForeName>Wei</ForeName>                    <Initials>W</Initials>                    <AffiliationInfo>                        <Affiliation>Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Fang</LastName>                    <ForeName>Yan</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Shen</LastName>                    <ForeName>Kunwei</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>12</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Korea (South)</Country>            <MedlineTA>J Breast Cancer</MedlineTA>            <NlmUniqueID>101314183</NlmUniqueID>            <ISSNLinking>1738-6756</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Transl Oncol. 2017 Dec;10(6):988-997</RefSource>                <PMID Version="1">29096247</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Struct Mol Biol. 2013 Jul;20(7):908-13</RefSource>                <PMID Version="1">23728290</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50</RefSource>                <PMID Version="1">16199517</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nucleic Acids Res. 2011 May;39(9):3864-78</RefSource>                <PMID Version="1">21247874</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2017 Mar 18;389(10074):1134-1150</RefSource>                <PMID Version="1">27865536</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Sci Rep. 2016 Aug 09;6:31038</RefSource>                <PMID Version="1">27503456</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biomark Cancer. 2013 Oct 29;5:61-70</RefSource>                <PMID Version="1">24250234</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2010 Nov 15;5(11):e13984</RefSource>                <PMID Version="1">21085593</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2015 Mar 17;17:40</RefSource>                <PMID Version="1">25849966</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Endocr Relat Cancer. 2009 Dec;16(4):1091-102</RefSource>                <PMID Version="1">19726539</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Bioinformatics. 2013 Nov 15;29(22):2877-83</RefSource>                <PMID Version="1">23958724</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nucleic Acids Res. 2009 Jan;37(1):1-13</RefSource>                <PMID Version="1">19033363</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2007 Jul 12;26(32):4656-67</RefSource>                <PMID Version="1">17297453</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Bioinformatics. 2016 Apr 1;32(7):1097-9</RefSource>                <PMID Version="1">26607490</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Genet. 2003 Jul;34(3):267-73</RefSource>                <PMID Version="1">12808457</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Bioinformatics. 2004 Feb 12;20(3):307-15</RefSource>                <PMID Version="1">14960456</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nucleic Acids Res. 2015 Feb 27;43(4):2466-85</RefSource>                <PMID Version="1">25628363</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2012;7(12):e51862</RefSource>                <PMID Version="1">23251644</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genome Res. 2012 Sep;22(9):1760-74</RefSource>                <PMID Version="1">22955987</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biostatistics. 2007 Jan;8(1):118-27</RefSource>                <PMID Version="1">16632515</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Pathol. 2005 Nov;58(11):1135-42</RefSource>                <PMID Version="1">16254100</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Bioinformatics. 2008 Oct 15;24(20):2395-6</RefSource>                <PMID Version="1">18697769</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2017 Jun 2;8(38):64638-64650</RefSource>                <PMID Version="1">28969100</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 1983 Aug;43(8):3583-5</RefSource>                <PMID Version="1">6861130</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Commun. 2016 Sep 26;7:12791</RefSource>                <PMID Version="1">27666543</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Protoc. 2009;4(1):44-57</RefSource>                <PMID Version="1">19131956</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2016 May;35(21):2746-55</RefSource>                <PMID Version="1">26364613</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2005 May 14-20;365(9472):1687-717</RefSource>                <PMID Version="1">15894097</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Biometrics. 2000 Jun;56(2):337-44</RefSource>                <PMID Version="1">10877287</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Hum Mol Genet. 2006 Apr 15;15 Spec No 1:R17-29</RefSource>                <PMID Version="1">16651366</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Breast neoplasms</Keyword>            <Keyword MajorTopicYN="N">Long noncoding RNA</Keyword>            <Keyword MajorTopicYN="N">Neoplasm metastasis</Keyword>            <Keyword MajorTopicYN="N">Prognosis</Keyword>            <Keyword MajorTopicYN="N">Tamoxifen</Keyword>        </KeywordList>        <CoiStatement>CONFLICT OF INTEREST: The authors declare that they have no competing interests.</CoiStatement>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>03</Month>                <Day>25</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>08</Month>                <Day>06</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>3</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>3</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>3</Day>                <Hour>6</Hour>                <Minute>1</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30275856</ArticleId>            <ArticleId IdType="doi">10.4048/jbc.2018.21.e39</ArticleId>            <ArticleId IdType="pmc">PMC6158153</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>